Solution mediated polymorphic transformations (SMPT) of the pharmaceutical compounds carbamazepine and piracetam have been investigated. Seeded transformation experiments were performed, and the solution concentration was monitored by in situ infra-red spectroscopy using a calibration free method. Solid samples were also taken over time, and the percentage of metastable and stable polymorphic phases were determined using off line quantitative powder X-ray diffraction analysis. Solution and solid state data were compared for each compound. In the case of carbamazepine, the SMPT from FI to FIII was identified as being controlled by the growth of the stable FIII polymorph.
under ambient conditions. FII is metastable, and FIII is the stable polymorph, as determined by melting points. Kuhnert-Brandstatter et al. claim that FII and FIII also have an enantiotropic relationship with a transition temperature above 75 °C 24 , but no experimental evidence exists to verify this claim. The solubility of FIII has been determined by Maher et al. 25 . Cooling crystallizations have shown the selection of FII or FIII PCM based on the solvent used 26 . In other studies using in situ energy dispersive X-ray diffraction, all three polymorphs were identified during cooling crystallizations with multiple solvents. FI formed initially but had a short lifetime and transformed to FII and/or FIII with continued cooling 27 . The FI polymorph of PCM was not seen for the transformation experiments performed here.
In this study, the solution mediated polymorphic transformation of FII to FIII PCM was monitored in ethanol at 50 °C. stable polymorph was achieved by dividing the peak area of the stable polymorph by the sum of the peak area of the metastable and stable polymorphs and expressing it as a percentage 28 . The % peak area of the metastable polymorph was then the remaining percentage in the mixture. Correlation curves were constructed from the % peak area of the stable polymorph measured by PXRD and the % w/w polymorph in the mixture.
CBZ and Methanol: Solution Concentration Monitoring
The solution concentration behaviour of CBZ in methanol was monitored qualitatively over time during the transformation with in situ ATR-FTIR (ReactIR iC10 with DiComp probe with silver halide fibre) using a calibration free method 8 . The intensity of the Infra-red absorption of the C=O stretch of CBZ in solution, represented by peak height or peak area, is proportional to its concentration 29 . This was used to monitor the concentration in solution during the transformation. In practice the ratio of the CBZ carbonyl absorbance at 1680cm -1 to the at methanol peak at 1120cm -1 (overtone band) was used as the signal to noise ratio for the CBZ carbonyl absorbance in methanol was quite weak. An ATR-FTIR measurement was taken every 30 s in the range from 650cm -1 to 1800cm -1 using iCIR software. A 100 mL jacketed glass vessel with magnetic stirring was used in conjunction with a Lauda E305 recirculator and E300 controller to ensure a constant temperature during the experiments. Methanol was presaturated with 4.95 g CBZ in 100 mL such that the solvent was almost saturated with respect to stable FIII CBZ polymorph at 10 °C. The solution was heated to 20 °C for 1hr, to ensure all the solid phase had dissolved, and then cooled to 10 °C and held for 30mins prior to the addition of 2.70 g FI CBZ solids.
Once the FI solids had been added and where the solution reached its plateau concentration, measured by ATR-FTIR during the transformation, a solution sample was taken to gravimetrically determine the solubility of FI CBZ in methanol at 10°C. At this point, FTIR data collection was paused and the stirring was switched off to allow the suspended solid to settle. A solution sample was carefully filtered into a pre-weighed vial and then weighed to determine the solution mass. After drying, the remaining solute was weighed and the concentration was expressed as g solute / g solvent. FIII CBZ solubility was determined in a similar manner.
PCM and Ethanol: Solution Concentration Monitoring
The solution concentration behaviour of PCM in ethanol was monitored over time during the transformation using the same ATR-FTIR measurements described above. Monitoring only the peak area absorbance at 1680cm -1 (C=O stretch) was necessary as the carbonyl absorbance for PCM in ethanol was quite strong. A 250 mL jacketed vessel with overhead stirring was used with the same recirculator and controller as described above. Ethanol was pre-saturated with 16.23 g PCM in 165mL
such that the solvent was saturated with respect to the stable FIII PCM polymorph at 50 °C. The solution was preheated to 60 °C for 30mins and then cooled to the experimental temperature of 50 °C and held for another 30mins prior to the addition of 3.28 g of FII solids.
FII PCM solubility was determined separately by slurrying FII PCM in excess in contact with ethanol.
Over time, the solid phase was monitored by PXRD. At the point where FIII PCM solid had just appeared in the solid phase a solution sample was taken to gravimetrically determine the solution concentration (as above). This was taken as the solubility of FII PCM. FIII PCM solubility has been determined elsewhere 25 .
Solid Phase monitoring
In both experiments, the solid phase was also monitored during the transformation by filtering some of the excess solid, at selected times, through a 0.22μm membrane using an Hirsch funnel under vacuum. It was assumed that this did not affect the concentration profile during the experiment as the sample taken was quite small (50-100 mg) and the reactor contents were well mixed. The dry solid was kept in a dessicator and later analysed by PXRD to determine the polymorphic composition during the solution mediated transformation.
RESULTS
The polymorphic forms of CBZ -FI and FIII, and PCM -FII and FIII were identified by PXRD, as shown in Figure 1 and 2, respectively. Both polymorphic forms agree well with the theoretical patterns and with those reported in the literature 24, 30 . The habit of each polymorph is also illustrated by the SEM images seen in Figure 3 . The solubility of the stable and metastable solid forms of both CBZ and PCM is presented in Table 1 .
The most stable polymorph will have the lowest solubility and this is seen for both systems. The data illustrate that there is a small but significant difference in solubility between the polymorphs. In both SMPTs, addition of the metastable solid polymorph to each solution resulted in a step increase in solution concentration. This indicated the fast dissolution of the metastable polymorph which resulted in the solution becoming saturated with respect to the metastable polymorph and supersaturated with respect to the stable polymorph. Over time, nucleation and then growth of the stable polymorph occurred at the expense of the dissolving metastable polymorph. Where the total rate of growth is compensated for by the much faster total rate of dissolution, a plateau in solution concentration/supersaturation is achieved and this has been previously identified by Cardew and Davey 9 . The evidence of a plateau region in both of the SMPT experiments presented here showed that the transformations were controlled by growth of the stable polymorph. Once all of the metastable polymorph had dissolved, the stable polymorph continued to grow until it was in equilibrium with the solution.
In Figure 6 , the polymorphic transformation of FI to FIII CBZ in methanol at 10 °C is shown.
Monitoring the polymorphic composition shows that the transformation has established itself after polymorph grew. This demonstrated that the total rate of growth was much faster than the total rate dissolution and that once nucleation occurred, the transformation to the stable phase was only controlled by dissolution of the metastable polymorph. The plateau in solution concentration resulted due to the induction time required to nucleate the stable form II polymorph and not because dissolution was comparatively more rapid than growth 9 . A very similar SMPT experiment was performed in the case of L-glutamic acid 4 where seeds of the metastable α form were added to a solution that was saturated with respect to the metastable α form. Interestingly, in contrast to the case of tolbutamide, during the plateau region of the solution concentration profile the stable β polymorph was seen to nucleate and grow immediately without any measurable induction time for nucleation (similar to the case of the CBZ FI to FIII SMPT presented above).
Combining these experimental data already present in the literature with those of this work, it is clear that four principal scenarios appear possible for solution mediated polymorphic transformations. In the schematic diagrams below these scenarios are sketched with the solution and solid state data considered in combination. In (a) and (b) of Figure 8 , the theoretical basis for the observed solution concentration/supersaturation profiles and solid state data has been established 9 . In both scenarios there is a very short induction time before the stable solid phase (e.g. polymorph, hydrate, etc.) appears, i.e. the nucleation of the stable phase is quite rapid. In scenario (a) the solution concentration drops immediately after any appreciable amount of the stable phase has been produced. In scenario (b), the solution concentration stays at the solubility of the metastable form for quite some time so that a plateau is established, and moreover, the plateau extends until almost no metastable solid form remains in the suspension. In this scenario the rate of consumption of supersaturation [g/L.s] by crystal growth of the stable form, over most of the transformation, is clearly lower than the overall rate of dissolution [g/L.s] of the metastable form. This case is denoted as "growth controlled polymorphic transformation". We would expect that this situation is more common than scenario (a), since the intrinsic rate of growth is expected to be lower than the intrinsic rate of dissolution. Otherwise, the same considerations over the influence of the solid-liquid interfacial surface areas apply for this case. It should be clearly recognised that the initial total surface area of the metastable form can be well controlled in the experiment, while the total surface area of the stable form is entirely governed by the number of crystals that are nucleated of that form, and with the present state of knowledge we have very little control over this.
Insofar as the solid state data is in line with the diagrams in Figure 8 there is an induction time prior to any of the stable form being detected. However, different to scenario (c) is that in scenario (d) the solution concentration does not start to decay until most of the metastable form has transformed to the stable form. Accordingly, the overall growth rate is clearly slower than the overall dissolution rate, for the same reasons as was discussed for case (b). We would like to name scenario (d) as a "nucleation-growth controlled polymorphic transformation" This scenario is been exemplified in SMPT experiments involving the compounds taltireline 33 , glycine 34 and for the SMPT of FII to FIII Piracetam presented here.
It is worth considering that the four principal scenarios described in Figure 8 could also be determined on the basis of nucleation behavior alone. On the assumption that the intrinsic rate of dissolution is greater than the intrinsic rate of growth (established previously in the text) the resultant scenario for SMPT should depend only on the nucleation behaviour. That is, when nucleation of the stable phase occurs and whether or not the nucleation of the stable phase results in a relatively large or small number of nuclei. The former has the effect as to whether or not an induction time will be detected whereas the latter will be a key determinant in the interfacial solid-liquid surface area of the stable phase available for growth. The four scenarios can be rationalised in terms of combinations of this nucleation behaviour.
If the nucleation occurs quickly, without the detectable presence of an induction time, with a prolific number of nuclei being present the interfacial solid-liquid surface area of the stable form is much higher than that of the metastable form over most of the transformation time. As a result, total growth rate of the stable phase will be ample so as to make the dissolution of the metastable phase the controlling step and this will result in scenario (a). If nucleation occurs quickly but the number of nuclei present is scarce the interfacial solid-liquid surface area of the stable phase is reduced and thus the total growth rate of the stable phase will also be reduced. This will result in the growth of the stable phase being the controlling step in the transformation. This is identified by scenario (b). In the case where nucleation does not occur quickly and there is a detectable induction time, the scenario that will result is again dependent on whether the number of nuclei that are present are in abundance or scarce. Scenario (c) and (d) have induction times for the appearance of the stable phase and thereafter are the same as that of scenarios (a) and (b), respectively. Allowing for the possibility of a detectable induction time, the boundaries between the different scenarios will depend on the growth rate of the stable phase which is directly influenced by the number of crystals of the stable phase that nucleate.
Experimental evidence for the scenarios described in Figure 8 is presented in Table 2 in more detail.
For each of the SMPT experiments listed, both solution and solid state data are presented. Accordingly, the classification for SMPTs derived above is applied to the work in references 4, 14, 32, 34 and 35 in Table 2 . The data set in Table 2 is obviously not intended to be an exhaustive review but some simple observations are worth noting. The data is for a number of different compounds over a range of temperatures and solvents. The specified scenario appears independent of the condition as to whether or not the solvent was saturated prior to addition of the metastable phase. The data shows no trend in scenario with respect to driving force (approximated using solubility ratio) for the solution mediated transformations.
The thermodynamic driving force for a solution mediated transformation of a metastable polymorph to a stable polymorph is independent of the solvent, and as a first approximation can be described by RTlnS, where S is the solubility ratio of the two forms. For the work reported here, the SMPT of FI to FIII CBZ has a calculated thermodynamic driving force of 0.8 kJ mol -1 whereas in the case of PCM the value is 0.05 kJ mol -1 , approximately 15 times smaller showing that there is a higher driving force for the SMPT of CBZ. We may note that for the CBZ system, where the driving force is relatively high, there is no appreciable nucleation induction time and the overall rate of transformation is relatively fast.
For the PCM system, where the driving force for transformation is relatively low, there is a clear induction time for nucleation and the overall rate of transformation is relatively slow. However, even though the activation energy for a nucleation controlled transformation (i.e. primary nucleation and/or 2-D nucleation growth) decreases with increasing thermodynamic driving force, the comparison of the rate of transformation for different systems cannot only be based on the available driving force. In fact, even for cases in Table 2 belonging to the same transformation scenario, it turns out that a system having a high driving force does not necessarily transform faster than a system having a lower driving force.
The transformation scenarios discussed above may also allude to molecular level mechanistic detail relevant to solution mediated transformations. For example, the solution mediated transformation of α to β L-glutamic acid is known to be facilitated by epitaxial contact between the polymorphic forms during the transformation 36, 37 . Examining the solution concentration in conjunction with the polymorphic composition data for the SMPT of α to β L-glutamic acid shows the immediate transformation from the α to the β form during the plateau region in solution concentration -i.e. there is no detectable induction time for the appearance of the stable β polymorph. Similar solution and solid state behaviour is seen in the case of the SMPT of FI to FIII CBZ presented here. Work is currently being undertaken to investigate if a crystal-crystal epitaxial relationship can be established for the SMPT of FI to FIII CBZ.
CONCLUSION
In situ ATR-FTIR was successfully employed in a calibration free manner to monitor the solution concentration profile during the solution mediated transformations of CBZ and PCM polymorphs. The relative polymorph composition was determined and the solid phase evolution was compared with the solution concentration profile. This experimental approach has allowed the SMPT process to be evaluated in greater detail, generating greater insight into the mechanism controlling these transformations. Both of the SMPTs presented in this work are characterised by a plateau region in solution concentration but when the composition of the solid state is overlaid and compared different behaviours of the solid state exist in this plateau region. In both systems, the overall rate of dissolution of the metastable form is fast compared to the overall rate of growth of the stable form. However, in the SMPT of CBZ, the stable polymorph readily nucleates and grows, but in the case of PCM, there is a considerable induction time prior to nucleation of the stable polymorph.
From a mechanistic point of view four different principal scenarios of polymorphic transformation are defined, based on the nucleation and growth behaviour of the stable phase and the rate of dissolution of the metastable phase. Within this framework on the basis of solution and solid phase information, each specific system can be classified.
